Press release
Chronic Rhinosinusitis Market: Driving Rapid Growth with Top Players and High Future CAGR by 2024-2031 | Lyra Therapeutics, Novartis, Medtronic plc.
Chronic Rhinosinusitis Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/chronic-rhinosinusitis-market
What is the projected growth rate (CAGR) of the Global Chronic Rhinosinusitis market from 2024 to 2031, and what is the market value expected to change by 2031?
Global Chronic Rhinosinusitis Market reached USD 2.6 billion in 2023 and is expected to reach USD 4.5 billion by 2031, growing with a CAGR of 7.3% during the forecast period 2024-2031.
What is Chronic Rhinosinusitis Market?
The Chronic Rhinosinusitis (CRS) market encompasses treatments, therapies, and devices focused on managing persistent inflammation of the sinuses, typically lasting over 12 weeks. Driven by factors like increased prevalence, advancements in biologics, and minimally invasive surgical options, this market addresses the demand for effective solutions to alleviate symptoms like nasal congestion, facial pain, and breathing difficulties, improving patient quality of life.
Who are the major players in the Chronic Rhinosinusitis market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Chronic Rhinosinusitis market research report are: Lyra Therapeutics, Novartis, Medtronic plc, GlaxoSmithKline plc, AstraZeneca, Sanofi, Dr. Reddy's Laboratories Ltd., Stryker Corporation, Bayer AG, and Smith & Nephew among others.
Key Development
On June 2, 2023, Lyra Therapeutics, Inc., a clinical-stage biotech company pioneering localized treatments for chronic rhinosinusitis (CRS), announced a new equity award under its 2022 Inducement Award Plan. This grant was made to Allison Nance, who joined the team as Senior Vice President of Regulatory Affairs. As part of this incentive, Ms. Nance received a non-qualified stock option to purchase 110,000 shares of Lyra's common stock.
On February 9, 2023, H2Ocean LLC shared promising results from a clinical study on Nasalzyme, their sea salt-based nasal spray. Nasalzyme, formulated with natural ingredients like Red Sea unrefined sea salt and natural enzymes, provides non-addictive relief for those suffering from chronic rhinosinusitis. This all-natural spray works to alleviate symptoms and improve comfort for individuals with CRS and similar sinus conditions.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=chronic-rhinosinusitis-market
Regions Covered:
The global Chronic Rhinosinusitis Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Market Segments
By Disease Phenotype: Non-Eosinophilic Chronic Rhinosinusitis, Eosinophilic Chronic Rhinosinusitis, Infectious Chronic Rhinosinusitis, Allergic Fungal Rhinosinusitis, Others.
By Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others.
The Chronic Rhinosinusitis industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Chronic Rhinosinusitis industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Chronic Rhinosinusitis innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Chronic Rhinosinusitis market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Chronic Rhinosinusitis
➥ Maximize market presence with brand share analysis, strengthening your position in the Chronic Rhinosinusitis landscape.
➥ Accurately predict market demand for Chronic Rhinosinusitis with precise drug sales forecasting insights.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/chronic-rhinosinusitis-market
FAQs
What does the Chronic Rhinosinusitis market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Chronic Rhinosinusitis market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Rhinosinusitis Market: Driving Rapid Growth with Top Players and High Future CAGR by 2024-2031 | Lyra Therapeutics, Novartis, Medtronic plc. here
News-ID: 3713186 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Rhinosinusitis
Chronic Rhinosinusitis (CRS) Market New Product Development & Latest Trends
Introduction
Chronic rhinosinusitis (CRS) is a persistent inflammatory condition of the paranasal sinuses lasting more than 12 weeks, characterized by nasal congestion, facial pain, loss of smell, and mucosal inflammation. Affecting millions worldwide, CRS significantly reduces quality of life and drives substantial healthcare costs due to its chronic nature and frequent relapses.
As awareness of CRS increases and treatment approaches expand beyond symptomatic relief to disease-modifying interventions, the global market for chronic…
Rhinosinusitis Market Size And Global Industry Forecast 2034
Introduction
The rhinosinusitis market focuses on the treatment and management of inflammation of the nasal cavity and paranasal sinuses, which can be acute or chronic in nature. Rhinosinusitis, often triggered by infections, allergies, or environmental factors, significantly impacts patient quality of life through nasal congestion, facial pain, headaches, and breathing difficulties.
The market is growing steadily due to rising pollution levels, increasing allergy prevalence, better diagnostic technologies, and the availability of advanced…
Chronic Rhinosinusitis with Nasal Polyps Market Worth $3.4 Billion by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Chronic Rhinosinusitis with Nasal Polyps Market- (By Treatment Type (Pharmacological Treatments (Corticosteroids, Antibiotics, Biologic Drugs, Antihistamines, Leukotriene Modifiers), Surgical Interventions, Others), By Route of Administration (Oral, Nasal, Injectable), By Distribution (Direct Sales, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialized Clinics and ENT Practices, Ambulatory Surgical Centers)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Growing Respiratory Disease Fuel Rise in Chronic Rhinosinusitis Market: Key Fact …
The Chronic Rhinosinusitis With Nasal Polyps Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Chronic Rhinosinusitis With Nasal Polyps Market Size During the Forecast Period?
The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will increase…
Chronic Rhinosinusitis with Nasal Polyps Pipeline Insights and Treatment Drugs 2 …
DelveInsight's, "Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight, 2024," report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Rhinosinusitis with Nasal Polyps pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs…
Acute Viral Rhinosinusitis Treatment Market to Explore Emerging Trends of Coming …
According to a Transparency Market Research (TMR) research report, the global acute viral rhinosinusitis treatment market is expected to reach US$ 3.16 Bn by the end of 2031. This suggests that the market is likely to expand at a CAGR of 5.3% during the forecast period, 2021 to 2031.
The business intelligence study on the market is prepared by employing industry-validated primary and secondary methods. The study uses these to collect…
